Promising Antitumor Activity After One ADC Dose in Breast Cancer Promising Antitumor Activity After One ADC Dose in Breast Cancer

Early data suggest that the antibody drug conjugate patritumab deruxtecan increases antitumor activity in early-stage breast cancer after a single dose.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news